Evidence map›Paper›PMID 40838944›Full record

Observational studyTranslational vision science & technology2025

Advanced Analysis Tools for Two Wavelength Autofluorescence Imaging of Macular Xanthophyll Carotenoids: ALSTAR2 Baseline.

Andreas Berlin, Lukas Goerdt, Mark E Clark, Liyan Gao, Thomas A Swain, Gerald McGwin, Cynthia Owsley, Kenneth R Sloan, Christine A Curcio

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04112667 (Functionally Validated Structural Endpoints for Early AMD), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04112667 completednot on this map

Functionally Validated Structural Endpoints for Early AMD

TypeobservationalSponsorCynthia OwsleyRan2019 to 2024Enrolled556ConditionsAge-related Macular Degeneration, AgingArmsNormal Macular Health, Early Macular Degeneration, Young Normals
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andreas BerlinOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Lukas GoerdtOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Mark E ClarkOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Liyan GaoOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Thomas A SwainOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Gerald McGwinOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Cynthia OwsleyOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Kenneth R SloanOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.
Christine A CurcioOphthalmology and Visual Sciences, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA.

Funding

Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul Douglas Gamlin · 1985 to 2026
$16.9M
Functionally Validated Structural Endpoints for Early AMDR01EY029595 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURCIO, CHRISTINE A, OWSLEY, CYNTHIA · 2019 to 2023
$4.1M
A hyperspectral approach to RPE fluorophores in AMDR01EY027948 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ACH, THOMAS, CURCIO, CHRISTINE A · 2017 to 2025
$3.8M
NEI NIH HHS P30 EY003039NEI NIH HHS R01 EY027948NEI NIH HHS R01 EY029595
6 · The paper itself

Abstract

Purpose: To allow exploration of xanthophyll carotenoids in vision and age-related macular degeneration progression using two-wavelength autofluorescence imaging for macular pigment optical density (MPOD), we developed tools for automatically centering and classifying the MPOD distribution pattern. Methods: A subset of the ALSTAR2 baseline cohort (NCT04112667) and 44 eyes of adults aged 20 to 30 years with healthy maculas were imaged with optical coherence tomography and two-wavelength autofluorescence (MPOD module, Heidelberg Engineering). Images underwent a quality review. Two custom FIJI plugins centered the MPOD distribution by five algorithms (FOVEA, HILLCLIMB, CENTROID, MAX, CONTOUR). Others automatically classified spatial distributions into four patterns from Obana et al: Peak, Ring, Mixed, and Dip. Results: Of 651 qualifying aged eyes and 44 young eyes, the HILLCLIMB and CONTOUR methods best agreed with a manually determined foveal center. Regarding spatial distribution pattern, 445 aged eyes (68.4%) showed peaks, 118 (18.1%) rings, 41 (6.3%) mixed, and 47 (7.2%) dips. In young eyes, 40 (90%) showed peaks, 1 (2.3%) rings, 3 (6.8%) mixed, and none showed dips. Notably, peaks were significantly (P < 0.001) more prominent in men (74.1%) than women (65.0%) and pseudophakic (72.7%) than phakic (62.9%) eyes. Conclusions: Automatic tools for MPOD centration are reliable and robust. Future studies will use the HILLCLIMB and CONTOUR algorithms. Translational Relevance: Automated MPOD pattern assignment suggests that the spatial distribution of MPOD varies with gender, lens status, and possibly age. Our analytic software can be applied to large samples for studies of xanthophyll carotenoid impact on vision and age-related macular degeneration progression.

Indexed as

CarotenoidsMacula LuteaMacular DegenerationMacular PigmentOptical ImagingXanthophyllsAdultAlgorithmsFemaleHumansMaleTomography, Optical CoherenceYoung AdultCarotenoidsMacular PigmentXanthophylls

Identifiers

PMID40838944
PMCPMC12393178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.